Table 2.
Association of CORO1C expression with clinicopathological parameters from gastric cancer patients.
| Parameter | n | CORO1C expression (n (%)) | P | χ2 | |
|---|---|---|---|---|---|
| Negative | Positive | ||||
| Age (years) | |||||
| ≤ 60 | 38 | 11 (28.9) | 27 (71.1) | 0.783 | 0.076 |
| > 60 | 42 | 11 (26.2) | 31 (73.8) | ||
| Gender | |||||
| Male | 44 | 12 (27.3) | 32 (72.7) | 0.960 | 0.003 |
| Female | 36 | 10 (27.8) | 26 (72.2) | ||
| Tumor size (cm) | |||||
| ≤ 5 | 48 | 14 (29.2) | 34 (70.8) | 0.683 | 0.167 |
| > 5 | 32 | 8 (25.0) | 24 (75.0) | ||
| Lymph node metastasis | |||||
| No | 28 | 13 (46.4) | 15 (53.6) | 0.005 | 7.741 |
| Yes | 52 | 9 (17.3) | 43 (82.7) | ||
| Grade | |||||
| I–II | 47 | 13 (27.7) | 34 (72.3) | 0.970 | 0.001 |
| III | 33 | 9 (27.3) | 24 (72.7) | ||
| Stage | |||||
| I–II | 28 | 12 (42.9) | 16 (57.1) | 0.024 | 5.096 |
| III–IV | 52 | 10 (19.2) | 42 (80.8) | ||